LA JOLLA PHARMACEUTICAL CO Accounts Receivable
LA JOLLA PHARMACEUTICAL CO had Accounts Receivable of $5.93 million as of 2022-06-30, per its 10-Q filed 2022-08-15.
Discontinued › Balance Sheet › Assets › Assets, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2022-08-15
- 2022-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $5.93M.
- 2022-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $5.73M.
- 2021-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $8.61M.
- 2021-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $8.79M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2022-06-30 | $5.93M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $5.73M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $8.61M 10-Q · filed 2022-08-15 |
| 2021-09-30 | $8.79M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $8.60M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $4.15M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $5.83M 10-K · filed 2022-03-09 |
| 2020-09-30 | $3.93M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $1.84M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $3.55M 10-Q · filed 2020-05-04 |
| 2019-12-31 | $2.96M 10-K · filed 2021-03-08 |
| 2019-09-30 | $1.42M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $1.89M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $2.00M 10-Q · filed 2019-05-06 |
| 2018-12-31 | $1.38M 10-K · filed 2020-03-02 |
| 2018-09-30 | $1.54M 10-Q · filed 2018-10-24 |
| 2018-06-30 | $372.00K 10-Q · filed 2018-08-08 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-04 |